C2C Wealth Management’s Moderna MRNA Stock Holding History

C2C Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell
2023 Q3	$567K	Sell
2023 Q2	$1.52M	Sell
2023 Q1	$2.42M	Buy
2022 Q4	$2.12M	Sell
2022 Q3	$1.44M	Sell
2022 Q2	$1.96M	Buy
2022 Q1	$1.49M	Sell
2021 Q4	$3.1M	Buy